These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8917823)
1. Sensitization of mice to topically applied drugs: albuterol, chlorpheniramine, clonidine and nadolol. Kalish R; Wood JA; Wille JJ; Kydonieus A Contact Dermatitis; 1996 Aug; 35(2):76-82. PubMed ID: 8917823 [TBL] [Abstract][Full Text] [Related]
2. Sensitization of mice to paraphenylenediamine and structurally-related compounds: adjuvant effects of vitamin A supplementation. Kalish RS; Wood JA Contact Dermatitis; 1995 Dec; 33(6):407-13. PubMed ID: 8706399 [TBL] [Abstract][Full Text] [Related]
3. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides. Polster AM; Warner MR; Camisa C Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065 [TBL] [Abstract][Full Text] [Related]
4. Effect of coadministration of corticosteroids on the development of contact sensitization. Amkraut AA; Jordan WP; Taskovich L J Am Acad Dermatol; 1996 Jul; 35(1):27-31. PubMed ID: 8682959 [TBL] [Abstract][Full Text] [Related]
5. Several different ion channel modulators abrogate contact hypersensitivity in mice. Wille JJ; Kydonieus A; Kalish RS Skin Pharmacol Appl Skin Physiol; 1999; 12(1-2):12-7. PubMed ID: 10325579 [TBL] [Abstract][Full Text] [Related]
6. Improved transdermal delivery of morin efficiently inhibits allergic contact dermatitis. Yu J; Wan K; Sun X Int J Pharm; 2017 Sep; 530(1-2):145-154. PubMed ID: 28739503 [TBL] [Abstract][Full Text] [Related]
7. Suppression of the contact hypersensitivity response following topical exposure to 2-butoxyethanol in female BALB/c mice. Singh P; Morris B; Zhao S; Blaylock BL Int J Toxicol; 2002; 21(2):107-14. PubMed ID: 12022630 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effects of clonidine on the induction of contact sensitization in the balb/c mouse. Robinson MK; Sozeri TJ J Invest Dermatol; 1990 Nov; 95(5):587-91. PubMed ID: 2230222 [TBL] [Abstract][Full Text] [Related]
9. Testing of controlled-release transdermal dosage forms. Product development and clinical trials. Shaw JE; Prevo ME; Amkraut AA Arch Dermatol; 1987 Nov; 123(11):1548-56. PubMed ID: 2960274 [TBL] [Abstract][Full Text] [Related]
10. Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice. Jung SH; Sun X; Ryu WS; Yang BS Br J Dermatol; 2013 Jan; 168(1):112-9. PubMed ID: 23020072 [TBL] [Abstract][Full Text] [Related]
11. Allergic contact dermatitis from dibucaine hydrochloride, chlorpheniramine maleate, and naphazoline hydrochloride in an over-the-counter topical antiseptic. Yamadori Y; Oiso N; Hirao A; Kawara S; Kawada A Contact Dermatitis; 2009 Jul; 61(1):52-3. PubMed ID: 19659969 [No Abstract] [Full Text] [Related]
12. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report. Corazza M; Mantovani L; Montanari A; Virgili A J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023 [TBL] [Abstract][Full Text] [Related]
13. Transdermal drug delivery systems of albuterol: in vitro and in vivo studies. Gokhale R; Schmidt C; Alcorn L; Stolzenbach J; Schoenhard G; Farhadieh B; Needham T J Pharm Sci; 1992 Oct; 81(10):996-9. PubMed ID: 1432626 [TBL] [Abstract][Full Text] [Related]
14. Impact of the magnitude of sensitization dose on the incidence and intensity of CHS to dinitrochlorobenzene (DNCB): insight from ear swelling and challenged-skin draining lymph node response in rats. Popov A; Mirkov I; Vasilijic S; Zolotarevski L; Kataranovski D; Kataranovski M J Immunotoxicol; 2013; 10(4):355-60. PubMed ID: 23614785 [TBL] [Abstract][Full Text] [Related]
15. Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management. Murphy M; Carmichael AJ Am J Clin Dermatol; 2000; 1(6):361-8. PubMed ID: 11702612 [TBL] [Abstract][Full Text] [Related]
16. Ethanol and diethyl phthalate: vehicle effects in the local lymph node assay. Lalko J; Isola D; Api AM Int J Toxicol; 2004; 23(3):171-7. PubMed ID: 15204720 [TBL] [Abstract][Full Text] [Related]
17. AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis. Bäumer W; Gorr G; Hoppmann J; Ehinger AM; Rundfeldt C; Kietzmann M J Pharm Pharmacol; 2003 Aug; 55(8):1107-14. PubMed ID: 12956900 [TBL] [Abstract][Full Text] [Related]
18. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. Sheu MY; Fowler AJ; Kao J; Schmuth M; Schoonjans K; Auwerx J; Fluhr JW; Man MQ; Elias PM; Feingold KR J Invest Dermatol; 2002 Jan; 118(1):94-101. PubMed ID: 11851881 [TBL] [Abstract][Full Text] [Related]
19. Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice. Tamura T; Masaki S; Ohmori K; Karasawa A Pharmacology; 2005 Dec; 75(1):45-52. PubMed ID: 15942272 [TBL] [Abstract][Full Text] [Related]
20. Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model. Bae J; Park JW Drug Dev Ind Pharm; 2016; 42(2):254-62. PubMed ID: 26006334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]